Guru Ownership Trend
Guru Analysis for Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $34.17 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $10.26 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 162.9%. Conversely, Murray Stahl reduced exposure by 4.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Vanda Pharmaceuticals Inc. (VNDA)
Major holders include Renaissance Technologies (RenTech) ($25.98 M), Cliff Asness ($11.08 M), Steven Cohen ($1.12 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 5.67 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.26 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited VNDA. The total reported sell value was $7,518.09.
Yes, 1 managers opened new positions in VNDA, and 4 increased their existing holdings. The total reported buy value was $10.26 M.